US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biofrontera Inc Warrant

0.0400

+0.007422.70%

Volume:3.00K

Turnover:118.08

Market Cap:- -

PE:- -

High:0.0401

Open:0.0399

Low:0.0300

Close:0.0326

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Biofrontera Inc Warrant

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

- -

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BFRIW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BFRIW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BFRIW\",,,,,undefined,":{"symbol":"BFRIW","market":"US","secType":"STK","nameCN":"Biofrontera Inc Warrant","latestPrice":0.04,"timestamp":1746216000000,"preClose":0.0326,"halted":0,"volume":3002,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":0.0074,"latestTime":"05-02 16:00:00 EDT","open":0.0399,"high":0.0401,"low":0.03,"amount":118.080597,"amplitude":0.309816,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":0,"adr":0,"listingDate":1635480000000,"exchange":"NASDAQ","adjPreClose":0.0326,"volumeRatio":0.7456903049897194},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BFRIW\",,,,,undefined,":{"symbol":"BFRIW","floatShares":0,"roa":"-35.18%","roe":"-325.31%","lyrEps":0,"volumeRatio":0.7456903049897194,"shares":0,"dividePrice":0,"high":0.0401,"amplitude":0.309816,"preClose":0.0326,"low":0.03,"week52Low":0.015,"pbRate":"0.00","psRate":"0.00","week52High":0.255,"institutionHeld":0,"latestPrice":0.04,"eps":0,"divideRate":0,"volume":3002,"delay":0,"ttmEps":0,"open":0.0399,"prevYearClose":0.0607,"prevWeekClose":0.0459,"prevMonthClose":0.0399,"prevQuarterClose":0.0602,"fiveDayClose":0.0459,"twentyDayClose":0.076,"sixtyDayClose":0.06},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":-0.1285},{"period":"1month","weight":-0.3355},{"period":"3month","weight":-0.3333},{"period":"6month","weight":-0.3919},{"period":"1year","weight":-0.3333},{"period":"ytd","weight":-0.341}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.203443},{"month":2,"riseRate":1,"avgChangeRate":1.641987},{"month":3,"riseRate":0.5,"avgChangeRate":-0.010062},{"month":4,"riseRate":0.25,"avgChangeRate":-0.076182},{"month":5,"riseRate":0.25,"avgChangeRate":-0.201946},{"month":6,"riseRate":0,"avgChangeRate":-0.257301},{"month":7,"riseRate":0,"avgChangeRate":-0.12779},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.009831},{"month":9,"riseRate":0,"avgChangeRate":-0.167874},{"month":10,"riseRate":0.666667,"avgChangeRate":1.72},{"month":11,"riseRate":0.25,"avgChangeRate":-0.177521},{"month":12,"riseRate":0.25,"avgChangeRate":-0.085441}],"exchange":"NASDAQ","name":"Biofrontera Inc Warrant","nameEN":"Biofrontera Inc Warrant"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BFRIW\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BFRIW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BFRIW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BFRIW\",market:\"US\",delay:false,,,undefined,":{}}}